Cargando…

Platelet-Derived Microparticles are an Important Biomarker in Patients with Cancer-Associated Thrombosis

BACKGROUND: Platelet-derived microparticles (PDMPs) that ultimately cause vascular complications might be used as a tool to assess thrombotic areas. We identified PDMPs, high-mobility group box-1 (HMGB1) and soluble endothelial protein C receptor (sEPCR) as useful prognosis indicators for cancer-rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamanaka, Yuta, Sawai, Yusuke, Nomura, Shosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997194/ https://www.ncbi.nlm.nih.gov/pubmed/32099444 http://dx.doi.org/10.2147/IJGM.S236166

Ejemplares similares

Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients
por: Sawai, Yusuke, et al.
Publicado: (2020)

Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricema
por: Nishizawa, Tohru, et al.
Publicado: (2015)

Microparticles as Biomarkers of Blood Coagulation in Cancer
por: Nomura, Shosaku, et al.
Publicado: (2015)

Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus
por: Nomura, Shosaku, et al.
Publicado: (2011)

Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β(1), and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia
por: Nomura, Shosaku, et al.
Publicado: (2018)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation
por: Nomura, Shosaku, et al.
Publicado: (2023)

Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer
por: Haghbeen, Marzieh, et al.
Publicado: (2021)

Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
por: Hu, Qianghua, et al.
Publicado: (2016)

Hepatocyte-derived Microparticles as Novel Biomarkers for the Diagnosis of Deep Venous Thrombosis in Trauma Patients
por: Zang, Xinwei, et al.
Publicado: (2023)

The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Platelet-Derived Microparticles and Autoimmune Diseases
por: Li, Xiaoshuai, et al.
Publicado: (2023)

Megakaryocyte- and Platelet-Derived Microparticles as Novel Diagnostic and Prognostic Biomarkers for Immune Thrombocytopenia
por: Wang, Wen, et al.
Publicado: (2022)

Breaking the Mold: Transcription Factors in the Anucleate Platelet and Platelet-Derived Microparticles
por: Lannan, Katie L., et al.
Publicado: (2015)

Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma
por: Nomura, Shosaku, et al.
Publicado: (2018)

Extracellular Vesicle-Related Thrombosis in Viral Infection
por: Nomura, Shosaku, et al.
Publicado: (2020)

Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016)

Platelet Microparticle Controversial Role in Cancer
por: Nazari, Mahnaz, et al.
Publicado: (2021)

Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study
por: Signorelli, Salvatore Santo, et al.
Publicado: (2020)

Platelet Pathogen Reduction Technologies Alter the MicroRNA Profile of Platelet-Derived Microparticles
por: Diallo, Idrissa, et al.
Publicado: (2020)

Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Plasma platelet-derived microparticles to platelet count ratio as a marker of mortality in critically ill patients
por: Ohuchi, M, et al.
Publicado: (2014)

Increased circulating platelet and endothelial-derived microparticles in patients with cardiac syndrome X
por: Ghaffari, Fereshteh, et al.
Publicado: (2021)

Platelet-derived microparticles serve as an important source of autoantigens and discriminate between levels of disease activity in systemic lupus erythematosus
por: Boilard, Eric, et al.
Publicado: (2014)

Platelet microparticles: a biomarker for recanalization in rtPA‐treated ischemic stroke patients
por: Bivard, Andrew, et al.
Publicado: (2017)

Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus
por: Burbano, Catalina, et al.
Publicado: (2018)

Polyphenols: Modulators of Platelet Function and Platelet Microparticle Generation?
por: Ed Nignpense, Borkwei, et al.
Publicado: (2019)

The relative importance of platelet integrins in hemostasis, thrombosis and beyond
por: Janus-Bell, Emily, et al.
Publicado: (2023)

Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease
por: Barrett, Tessa J., et al.
Publicado: (2020)

Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger’s disease) exacerbation
por: Darnige, L, et al.
Publicado: (2010)

Platelet-Derived Microparticles Bearing PF4 and Anti-GAGS Immunoglobulins in Patients with Sepsis
por: Sartori, Maria Teresa, et al.
Publicado: (2020)

Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism
por: Signorelli, Salvatore Santo, et al.
Publicado: (2020)

Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
por: Xu, Minjie, et al.
Publicado: (2023)

Examination of biomarker expressions in sepsis-related DIC patients
por: Shimizu, Michiomi, et al.
Publicado: (2018)

Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk
por: Papadavid, Evangelia, et al.
Publicado: (2016)

Increased levels of reactive oxygen species in platelets and platelet-derived microparticles and the risk of respiratory failure in HIV/AIDS patients
por: Gama, Wellington Mota, et al.
Publicado: (2020)

Generation of platelet-derived microparticles through the activation of the toll-like receptor 4
por: Alarcón, M.
Publicado: (2019)

Engineered human platelet-derived microparticles as natural vectors for targeted drug delivery
por: Kailashiya, Jyotsna, et al.
Publicado: (2019)

Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD
por: Tőkés-Füzesi, Margit, et al.
Publicado: (2018)

New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
por: Niki, Maiko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pe6ianndkaokd2mt4liga3rc04